Results 11 to 20 of about 131,546 (304)

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers [PDF]

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Our objective was to determine patterns of antihypertensive agent use by stage of chronic kidney disease (CKD) and to evaluate the association between different classes of antihypertensive agents with nonrenal outcomes, especially in advanced ...
Elaine Ku   +4 more
doaj   +3 more sources

High-Dose Insulin Euglycemic Therapy in Concomitant Beta-Blocker and Calcium Channel Blocker Overdose [PDF]

open access: yesJournal of Investigative Medicine High Impact Case Reports
Beta-blockers and calcium channel blockers are among the most commonly used drugs in the adult population, and the National Poison Data System annual reports note 11 075 beta-blocker overdoses and 6256 calcium-channel blocker overdoses in 2022. Poisoning
Varun Roperia MD   +2 more
doaj   +2 more sources

Calcium Channel Blocker Toxicity: A Practical Approach [PDF]

open access: yesJournal of Multidisciplinary Healthcare, 2022
Omar A Alshaya,1– 3 Arwa Alhamed,3,4 Sara Althewaibi,1 Lolwa Fetyani,1 Shaden Alshehri,1 Fai Alnashmi,1 Shmeylan Alharbi,1– 3 Mohammed Alrashed,1– 3,5 Saleh F Alqifari,6 Abdulrahman I Alshaya1– 3 1Department of Pharmacy Practice, College of Pharmacy ...
Alshaya OA   +9 more
doaj   +2 more sources

Prolonged Refractory Hypotension following Combined Amlodipine and Losartan Ingestion Responsive to Metaraminol [PDF]

open access: yesCase Reports in Medicine, 2011
Introduction. Overdose with the calcium channel blocker amlodipine can cause profound hypotension that may be exacerbated by the concurrent ingestion of an angiotensin II receptor antagonist.
James O. M. Plumb   +3 more
doaj   +4 more sources

Vasorelaxant Effect of a Newly Synthesized Dihydropyridine Ethyl Ester (DHPEE) on Rat Thoracic Aorta: Dual Mechanism of Action [PDF]

open access: yesAdvanced Pharmaceutical Bulletin, 2011
Introduction: DHPEE is a newly synthesized compound by merging the key structural elements in an angiotensin receptor blocker (Telmisartan) with key structural elements in 1,4- dihydropyridine calcium channel blocker (Nifedipine).
Hossein Babaei   +4 more
doaj   +2 more sources

Successful treatment of severe calcium channel blocker poisoning, new experience with the guidance of invasive hemodynamic monitoring in a 17-year-old girl: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Calcium channel blocker poisoning is one of the most lethal cardiac drugs overdoses. Calcium and high-dose insulin infusion are the first-line therapy for symptomatic patients, and Intralipid emulsion infusion is useful for refractory cases ...
Amir Saeed, Amir Naghshzan
doaj   +2 more sources

Effect of Dihydropyridine Calcium Channel Blocker on Mortality of Hypertension Patients With Moderate-Severe Pulmonary Acute Respiratory Distress Syndrome: A Multicenter Retrospective Observational Cohort Study

open access: yesCritical Care Explorations, 2021
OBJECTIVES:. The aim was to evaluate the effect of dihydropyridine calcium channel blocker on the prognosis for moderate-severe pulmonary acute respiratory distress syndrome in hypertension patients. DESIGN:.
Fengyuan Li, MD   +9 more
doaj   +1 more source

Intravenous calcium therapy in calcium channel blocker poisoning – A double-edged sword [PDF]

open access: yesJournal of Anaesthesiology Clinical Pharmacology
Balaji Rajaram   +3 more
doaj   +2 more sources

Development of severe junctional bradycardia after dexmedetomidine infusion in a polypharmacy patient: a case report and literature review [PDF]

open access: yesKosin Medical Journal, 2023
The authors report a case of newly manifested severe junctional bradycardia following dexmedetomidine administration during spinal anesthesia in a polypharmacy patient.
Soeun Jeon   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy